Kailash Chaurasiya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kailash Chaurasiya has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Elena Kireeva
From the Department of Nuclear Medicine and PET/CT, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia
2 shared publications- Elena Kireeva2 shared publications
Maxim Dunaikin
2 shared publications- Tatyana Shamanskaya
Federal Research Center of Pediatric Hematology, Oncology, and Immunology named after Dmitry Rogachev
2 shared publications - Yu. N. Likar
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
2 shared publications Yury Likar
From the Department of Nuclear Medicine and PET/CT, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia
2 shared publications
Latest Publications
- 20 October 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 51 (12) , 1104-1106
Unusual Isolated Thymic Relapse of Neuroblastoma Detected By 123I-mIBG Scintigraphy in a Pediatric Patient
Neuroblastoma (NB) is the most common extracranial solid malignancy of childhood, arising from neural crest cells of the sympathetic nervous system. Metastatic spread most frequently involves the bone marrow, bones, lymph nodes, and liver, whereas soft-tissue, central nervous system, and pulmonary metastases are less common. Unusual sites of recurrence may present a significant diagnostic challenge. We report a rare case of thymic relapse of NB presenting as an anterior mediastinal mass with intense uptake on 123 I-meta-iodobenzylguanidine ( 123 I-mIBG) scintigraphy. This case highlights an uncommon pattern of NB recurrence and the value of 123 I-mIBG imaging in its detection.
- 20 October 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 51 (12) , 1104-1106
Unusual Isolated Thymic Relapse of Neuroblastoma Detected By 123I-mIBG Scintigraphy in a Pediatric Patient
Neuroblastoma (NB) is the most common extracranial solid malignancy of childhood, arising from neural crest cells of the sympathetic nervous system. Metastatic spread most frequently involves the bone marrow, bones, lymph nodes, and liver, whereas soft-tissue, central nervous system, and pulmonary metastases are less common. Unusual sites of recurrence may present a significant diagnostic challenge. We report a rare case of thymic relapse of NB presenting as an anterior mediastinal mass with intense uptake on 123 I-meta-iodobenzylguanidine ( 123 I-mIBG) scintigraphy. This case highlights an uncommon pattern of NB recurrence and the value of 123 I-mIBG imaging in its detection.
- 4 September 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
Unexpected ¹⁸F-DOPA Uptake in Pediatric Posterior Mediastinal Ewing Sarcoma: A Diagnostic Pitfall in Pediatric Oncology
¹⁸F-DOPA PET/CT is a well-established imaging modality in pediatric nuclear medicine, with applications in both oncologic and nononcologic conditions. Common indications include brain tumors, neuroendocrine neoplasms, neuroblastoma, and congenital hyperinsulinism. Here, we present an unusual case of ¹⁸F-DOPA uptake in Ewing sarcoma. This case illustrates a potential diagnostic pitfall, emphasizing that ¹⁸F-DOPA avidity is not specific for neuroendocrine or neuroblastic tumors and may occur in non-neuroendocrine malignancies.
- 4 September 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
Unexpected ¹⁸F-DOPA Uptake in Pediatric Posterior Mediastinal Ewing Sarcoma: A Diagnostic Pitfall in Pediatric Oncology
¹⁸F-DOPA PET/CT is a well-established imaging modality in pediatric nuclear medicine, with applications in both oncologic and nononcologic conditions. Common indications include brain tumors, neuroendocrine neoplasms, neuroblastoma, and congenital hyperinsulinism. Here, we present an unusual case of ¹⁸F-DOPA uptake in Ewing sarcoma. This case illustrates a potential diagnostic pitfall, emphasizing that ¹⁸F-DOPA avidity is not specific for neuroendocrine or neuroblastic tumors and may occur in non-neuroendocrine malignancies.
- 24 April 2023
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 48 (6) , e316-e317
Primary Neuroblastoma of the Thymus
Primary neuroblastoma is the most common extracranial solid tumor in children and may occur anywhere along the sympathetic chain, but most commonly occur in abdominal/retroperitoneal region including the adrenal glands, followed by the thorax. In children, the most primary neuroblastomas in the thorax are in the posterior mediastinum. We present herein an extremely rare case of primary neuroblastoma of thymus in pediatric patient.
- 24 April 2023
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 48 (6) , e316-e317
Primary Neuroblastoma of the Thymus
Primary neuroblastoma is the most common extracranial solid tumor in children and may occur anywhere along the sympathetic chain, but most commonly occur in abdominal/retroperitoneal region including the adrenal glands, followed by the thorax. In children, the most primary neuroblastomas in the thorax are in the posterior mediastinum. We present herein an extremely rare case of primary neuroblastoma of thymus in pediatric patient.
- 17 April 2023
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 48 (7) , 581-585
Role of Preoperative Hepatobiliary Scintigraphy in Children Requiring Liver Resection
Purpose: The risk of posthepatectomy liver failure (PHLF) remains an important concern following major liver resection. Assessment of future remnant liver function (FRLF) by hepatobiliary scintigraphy has shown its significance to prevent PHLF after major liver resection in adults with a threshold value of FRLF greater than 2.7%/min per m2. However, such data for pediatric patients were not published. Methods: A total of 77 pediatric patients with liver tumors who underwent 1-stage liver resection were included in this study. Assessment of FRLF, future remnant liver volume (FRLV), and the ratio of remnant liver volume to body weight (RLV-BWR) was performed before the surgery. Results: All patients had RLV-BWR values of more than 0.5%/kg. Future remnant liver volume values ranged from 19% to 89%, and FRLF values ranged from 1.8% to 31.8%/min per m2. Only 7 of 77 patients had FRLV values less than 25%, but their FRLF values exceeded 2.7%/min per m2. Two patients developed grade A and grade B PHLF. Conclusion: Future remnant liver volume and the RLV-BWR can be used in most pediatric patients for the assessment of liver before hepatectomy. According to our data, implementation of FRLF assessment using hepatobiliary scintigraphy can be most beneficial for children with FRLV of less than 25%. The cutoff value of FRLV greater than 25% can be slightly decreased with minimal risk of developing PHLF. However, to establish a new cutoff value for FRLV in children, further prospective studies including larger numbers of patients with FRLV of less than 25% are needed.
- 17 April 2023
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 48 (7) , 581-585
Role of Preoperative Hepatobiliary Scintigraphy in Children Requiring Liver Resection
Purpose: The risk of posthepatectomy liver failure (PHLF) remains an important concern following major liver resection. Assessment of future remnant liver function (FRLF) by hepatobiliary scintigraphy has shown its significance to prevent PHLF after major liver resection in adults with a threshold value of FRLF greater than 2.7%/min per m2. However, such data for pediatric patients were not published. Methods: A total of 77 pediatric patients with liver tumors who underwent 1-stage liver resection were included in this study. Assessment of FRLF, future remnant liver volume (FRLV), and the ratio of remnant liver volume to body weight (RLV-BWR) was performed before the surgery. Results: All patients had RLV-BWR values of more than 0.5%/kg. Future remnant liver volume values ranged from 19% to 89%, and FRLF values ranged from 1.8% to 31.8%/min per m2. Only 7 of 77 patients had FRLV values less than 25%, but their FRLF values exceeded 2.7%/min per m2. Two patients developed grade A and grade B PHLF. Conclusion: Future remnant liver volume and the RLV-BWR can be used in most pediatric patients for the assessment of liver before hepatectomy. According to our data, implementation of FRLF assessment using hepatobiliary scintigraphy can be most beneficial for children with FRLV of less than 25%. The cutoff value of FRLV greater than 25% can be slightly decreased with minimal risk of developing PHLF. However, to establish a new cutoff value for FRLV in children, further prospective studies including larger numbers of patients with FRLV of less than 25% are needed.